Gurmukteshwar Singh, MD

@drmootravardhak.bsky.social

Nephrologist (kidney doctor), Director of post-AKI care, Clinician-researcher-educator-father. Home dialysis champion. Views are personal, not employer’s. #Nephsky

Isn’t this just a set up for selection bias by indication? How do you retrospectively “target trial” emulate a contrast CT? Patients who got contrast post AKI could have unmeasurable illness. Patients who didn’t get it were obviously doing ok. @kidneyboy.bsky.social @hswapnil.medsky.social

American Journal of Kidney Diseases@ajkd.bsky.social · 13h ago

Kidney Outcomes After Contrast Exposure in Patients Recovering From Dialysis-Requiring Acute Kidney Injury: A Target Trial Emulation Study bit.ly/4wsFue2

Any experience with generic budesonide versus Tarpeyo(targeted release budesonide) for IgA nephropathy? All I can find are proteinuria studies and increased risk of systemic side effects. Blue Cross wants patient to fail generic budesonide for 3 months before approving Tarpeyo. #askrenal

Critical need for control group reform in RCTs. If you are seeking FDA approval by comparing to placebo or a weak control, your drug should be subject to price controls at 1.5x the current Rx. If you want premium pricing, pony up $$$ and do a comparative effectiveness trial against a strong control

a man with a surprised look on his face is asking what would i tell them

ALT: a man with a surprised look on his face is asking what would i tell them

media.tenor.com

National Kidney Foundation@kidney.org · 5mo ago

Kick up your #hydration game! 🚰 Staying hydrated is a great way to support your kidney health. If you have kidney disease, speak to your doctor about how much you should be drinking to protect your kidney function. Love, Kenny the Kidney! 🧡 #heartyourkidneys

Not sure about the conclusion. It’s not a randomized study so only patients with clinical equipoise would have undergone a biopsy. The results just show nephrologists’ pre-test intuitions are quite good.

ASN Publications@asnpublications.bsky.social · 5mo ago

This #ASNKidney360 study evaluated the concordance of pre-biopsy clinical diagnosis with post-biopsy final diagnosis among patients with clinical AKI. Read the article here: kidney.pub/KID1151 Steve Coca

And why did finerenone get away with it? Kerendia is being prescribed right and left now because they had the RCT data and FDA approval. But it’s very clear to me that old MRAs r just as protective, just lacked the RCT data for non medical circumstances. An unpopular opinion, but I own it.

IgA is pronounced eye-gee-ay The reason the disease should be called "eye-gee-ay nephropathy" is because IgA is central to the pathogenic mechanism. Moving to eye-gan is moving away from describing the disease by its pathogenic mechanism.

“If you have abdominal pain on the right, upper or lower, around belly button or lower, severe, throbbing, in one spot or moving around, go to the ER (not PCP or urgent care)”- HuffPost Next article coming soon: “Crisis: How ER visits drive up healthcare costs” www.huffpost.com/entry/stomac...

If Your Stomach Pain Feels Like This, It's Time To Go To The ER

Don't dismiss these red flags — they could warrant medical attention.

huffpost.com

Once upon a time, some villagers came across a large, ornate wooden box in the local woods. On the side of the box was a message: “Whatever money you put in this box will, in future, grow to become 2.5 times larger.” 1/

Interesting thread by James Heather about the indirect rate caps by the #NIH . It is not the first time this comes up e.g. both the Obama and the 1st DJT admin tried to cap them (with fierce discussions on Twitter back in 2017).

JAMES HEATHERS (@jamesheathers.bsky.social)

I have a piece half-done on the entire world of indirect costs. It's too big an endeavor to finish now, in the middle of the night, when this problem *that was always a live grenade with a…

buff.ly